Evidence map›Paper›PMID 35464159›Full record

ArticleCytotechnology2022

Perilla pomace obtained from four different varieties have different levels and types of polyphenols and anti-allergic activity.

Yuba Raj Gaihre, Akira Iwamoto, Shigeki Oogai, Hiroshi Hamajima, Keisuke Tsuge, Yasuo Nagata, Teruyoshi Yanagita

Open access · greenAbstract read
In one paragraph

Article in Cytotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Role and Mechanism ofMolecules (Basel, Switzerland) · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yuba Raj GaihreSaga Foods & Cosmetics Laboratory, Division of Research and Development Promotion, Saga Prefectural Regional Industry Support Center, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.ORCID 0000-0003-2743-0791
Akira IwamotoIndustrial Technology Center of Saga, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.
Shigeki OogaiSaga Foods & Cosmetics Laboratory, Division of Research and Development Promotion, Saga Prefectural Regional Industry Support Center, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.ORCID 0000-0002-4355-1465
Hiroshi HamajimaSaga Foods & Cosmetics Laboratory, Division of Research and Development Promotion, Saga Prefectural Regional Industry Support Center, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.
Keisuke TsugeIndustrial Technology Center of Saga, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.
Yasuo NagataSaga Foods & Cosmetics Laboratory, Division of Research and Development Promotion, Saga Prefectural Regional Industry Support Center, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.ORCID 0000-0001-8995-1109
Teruyoshi YanagitaSaga Foods & Cosmetics Laboratory, Division of Research and Development Promotion, Saga Prefectural Regional Industry Support Center, 114 Yaemizo, Nabesima-machi, Saga, 849-0932 Japan.ORCID 0000-0001-8187-2924
Saga Prefectural Regional Industry Support Center · JPSaga University · JPUniversity of Nagasaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-allergyApigeninDegranulationLuteolinPerilla pomaceRosmarinic acid

Identifiers

PMID35464159
PMCPMC8975982
OpenAlexW4210962048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.